Interactions of Amyloid-β with Membrane Proteins

被引:28
|
作者
Wiatrak, Benita [1 ,2 ]
Piasny, Janusz [1 ]
Kuzniarski, Amadeusz [3 ]
Gasiorowski, Kazimierz [2 ]
机构
[1] Wroclaw Med Univ, Dept Pharmacol, Mikulicza Radeckiego 2, PL-50345 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Basic Med Sci, Borowska 211, PL-50556 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Prosthet Dent, Krakowska 26, PL-50425 Wroclaw, Poland
关键词
Alzheimer's disease; amyloid-beta; NMDA receptor; PrPC protein; Fyn kinase; A-BETA; ALZHEIMERS-DISEASE; A-BETA(1-40) PEPTIDE; PRECURSOR PROTEIN; AGGREGATION; TAU; NEUROTOXICITY; OLIGOMERS; CLEAVAGE; RESIDUE;
D O I
10.3390/ijms22116075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In developing and developed countries, an increasing elderly population is observed. This affects the growing percentage of people struggling with neurodegenerative diseases, including Alzheimer's disease. Nevertheless, the pathomechanism of this disease is still unknown. This contributes to problems with early diagnosis of the disease as well as with treatment. One of the most popular hypotheses of Alzheimer's disease is related to the pathological deposition of amyloid-beta (A beta) in the brain of ill people. In this paper, we discuss issues related to A beta and its relationship in the development of Alzheimer's disease. The structure of A beta and its interaction with the cell membrane are discussed. Not only do the extracellular plaques affect nerve cells, but other forms of this peptide as well.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Effects of Cu(II) on the aggregation of amyloid-β
    Weibull, Martina G. M.
    Simonsen, Signe
    Oksbjerg, Cecilie R.
    Tiwari, Manish K.
    Hemmingsen, Lars
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2019, 24 (08): : 1197 - 1215
  • [42] Tau aggregation and its interplay with amyloid-β
    Nisbet, Rebecca M.
    Polanco, Juan-Carlos
    Ittner, Lars M.
    Goetz, Juergen
    ACTA NEUROPATHOLOGICA, 2015, 129 (02) : 207 - 220
  • [43] Facile Methodology for Monitoring Amyloid-β Fibrillization
    Cook, Nathan P.
    Marti, Angel A.
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (11): : 896 - 899
  • [44] Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β
    Huang, Zhenting
    Yan, Qian
    Wang, Yangyang
    Zou, Qian
    Li, Jing
    Liu, Zhou
    Cai, Zhiyou
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (02) : 505 - 514
  • [45] Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
    Coomans, Emma M.
    van Westen, Danielle
    Binette, Alexa Pichet
    Strandberg, Olof
    Spotorno, Nicola
    Serrano, Geidy E.
    Beach, Thomas G.
    Palmqvist, Sebastian
    Stomrud, Erik
    Ossenkoppele, Rik
    Hansson, Oskar
    BRAIN, 2024, 147 (03) : 949 - 960
  • [46] Ionic Environment Affects Biomolecular Interactions of Amyloid-β: SPR Biosensor Study
    Hemmerova, Erika
    Springer, Tomas
    Kristofikova, Zdenka
    Homola, Jiri
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 11
  • [47] Amyloid-β-neuropeptide interactions assessed by ion mobility-mass spectrometry
    Soper, Molly T.
    DeToma, Alaina S.
    Hyung, Suk-Joon
    Lim, Mi Hee
    Ruotolo, Brandon T.
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2013, 15 (23) : 8952 - 8961
  • [48] Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets
    Khondker, Adree
    Alsop, Richard J.
    Rheinstadter, Maikel C.
    MEMBRANES, 2017, 7 (03)
  • [49] High-Throughput Screening at the Membrane Interface Reveals Inhibitors of Amyloid-β
    Cox, Sarah J.
    Lam, Brian
    Prasad, Ajay
    Marietta, Hannah A.
    Stander, Nicholas, V
    Joel, Joseph G.
    Sahoo, Bikash R.
    Guo, Fucheng
    Stoddard, Andrea K.
    Ivanova, Magdalena I.
    Ramamoorthy, Ayyalusamy
    BIOCHEMISTRY, 2020, 59 (24) : 2249 - 2258
  • [50] The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
    Porter, Tenielle
    Bharadwaj, Prashant
    Groth, David
    Paxman, Adrian
    Laws, Simon M.
    Martins, Ralph N.
    Verdile, Giuseppe
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (03) : 895 - 905